Drawing for SXT SMART XROSS-LINKING TECHNOLOGY

USPTO serial 79357359

SXT SMART XROSS-LINKING TECHNOLOGY

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
VAGHANI, MAYUR C
Law office
TMO LAW OFFICE 124 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with SXT SMART XROSS-LINKING TECHNOLOGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals; dietetic foods adapted for medical purposes; dietetic substances adapted for medical use; dietary supplements for humans; amino acids for medical purposes; albumin dietary supplements; albuminous preparations for medical purposes; chemical preparations for pharmaceutical purposes; chemical preparations for medical purposes; chemico-pharmaceutical preparations; moist wipes impregnated with a pharmaceutical lotion; disinfectants for hygiene purposes; pharmaceuticals; acids for pharmaceutical purposes; medicinal infusions; balms for pharmaceutical purposes; mineral dietary supplements; eyepatches for medical purposes; medical preparations for slimming purposes; diet capsules; slimming pills; food supplements; pomades for medical purposes; pharmaceutical preparations for skin care; skin relief serum [medicated]; skin calming serum [medicated]; antitoxic sera; antioxidant pills; medicinal hair growth preparations; medicinal hair growth preparations; medicinal hair growth preparations; disinfectants; washes (disinfectant -) [other than soap]; hand-sanitizing preparations; antiseptic washing preparations; disinfectants and antiseptics; medical preparations; pharmaceutical preparations and products, pharmacological preparations, pharmacological preparations, chemical products and preparations all for medical purposes; pharmaceutical preparations and products, pharmacological preparations and pharmacological preparations and chemical products and preparations for use in the following fields: medical aesthetics and skin care (terms too vague in the opinion of the International Bureau Rule 13 (2) (b) of the Regulations); cosmeceuticals, all for medical purposes or for therapeutic purposes; skin care preparations for medical use; dermatological preparations, dermatological preparations; skin lotion (terms too vague in the opinion of the International Bureau Rule 13 (2) (b) of the Regulations), medicated skin creams, skin tonics for medical purposes, medicated skin care preparations, medical preparations for skin care sold exclusively in: medical clinics, medical aesthetics clinics, beauty clinics and plastic surgery clinics and in medical spas and aesthetic medicine practices; pharmaceuticals, pharmacological preparations, chemical preparations, the aforesaid goods sold in filled syringes (terms too vague in the opinion of the International Bureau Rule 13 (2) (b) of the Regulations); filled syringes, for medical use; injectable dermal fillers; dermatological and pharmaceutical products injected into or under the skin, into or under mucous membranes for filling, remodelling, giving volume to any part of the human body or for skin moisturising; filled syringes for medical purposes [containing pharmaceuticals]; chemical preparations for medical purposes; pre-filled syringes for medical purposes; dermal fillersACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 2, 2026ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Mar 12, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED
Dec 21, 2024FINTFINAL DECISION TRANSACTION PROCESSED BY IB
Nov 29, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB
Nov 29, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 27, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 8, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 8, 2024OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 28, 2023MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 28, 2023MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 28, 2023ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jun 13, 2023RFNTREFUSAL PROCESSED BY IB
May 17, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 17, 2023RFRRREFUSAL PROCESSED BY MPU
Mar 29, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 28, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 23, 2023DOCKASSIGNED TO EXAMINER
Dec 16, 2022MAFRAPPLICATION FILING RECEIPT MAILED
Dec 12, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 8, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance